Your browser doesn't support javascript.
loading
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
Shimada, Yuichi J; Bansilal, Sameer; Wiviott, Stephen D; Becker, Richard C; Harrington, Robert A; Himmelmann, Anders; Neely, Benjamin; Husted, Steen; James, Stefan K; Katus, Hugo A; Lopes, Renato D; Steg, Ph Gabriel; Storey, Robert F; Wallentin, Lars; Cannon, Christopher P.
Afiliação
  • Shimada YJ; Harvard Clinical Research Institute, Boston, MA; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Bansilal S; Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Wiviott SD; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Becker RC; Division of Cardiovascular Health and Disease, Heart, Lung and Vascular Institute, University of Cincinnati College of Medicine, Cincinnati, OH.
  • Harrington RA; Department of Medicine, Stanford University, Stanford, CA.
  • Himmelmann A; AstraZeneca Research and Development, Mölndal, Sweden.
  • Neely B; Duke Clinical Research Institute, Duke University, Medical Center, Durham, NC.
  • Husted S; Medical Department, Hospital Unit West, Herning/Holstebro, Denmark.
  • James SK; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
  • Katus HA; Medizinishe Klinik, Universitätsklinikum Heidelberg, Heidelberg, Germany.
  • Lopes RD; Duke Clinical Research Institute, Duke University, Medical Center, Durham, NC.
  • Steg PG; INSERM-Unité 1148, Paris, France; Assistance Publique-Hôpitaux de Paris, Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Paris, France; Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France; NHLI Imperial College, ICMS, Royal Brompton Hospital, London, United Kingdom.
  • Storey RF; Department of Cardiovascular Science, University of Sheffield, Sheffield, United Kingdom.
  • Wallentin L; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
  • Cannon CP; Harvard Clinical Research Institute, Boston, MA; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: christopher.cannon@hcri.harvard.edu.
Am Heart J ; 177: 1-8, 2016 Jul.
Article em En | MEDLINE | ID: mdl-27297843
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ticlopidina / Inibidores da Agregação Plaquetária / Adenosina / Complexo Glicoproteico GPIIb-IIIa de Plaquetas / Síndrome Coronariana Aguda / Antagonistas do Receptor Purinérgico P2Y Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ticlopidina / Inibidores da Agregação Plaquetária / Adenosina / Complexo Glicoproteico GPIIb-IIIa de Plaquetas / Síndrome Coronariana Aguda / Antagonistas do Receptor Purinérgico P2Y Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article